Vitruvias Therapeutics competitorsClear all

Vitruvias Therapeutics's top competitors include Sarepta Therapeutics, Adverum Biotechnologies, Arrowhead Pharmaceuticals and Intellia Therapeutics.
Vitruvias Therapeutics
Vitruvias Therapeutics
Vitruvias Therapeutics is a generic pharmaceutical company with a focus on developing niche topical generic products that are sold only by prescription.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Adverum Biotechnologies
Adverum Biotechnologies
Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.
Intellia Therapeutics
Intellia Therapeutics
Intellia is developing therapeutic products to help people with genetic diseases.
Founding Date
Founding Date
2013
Founding Date
1980
Founding Date
2006
Founding Date
2004
Founding Date
2014
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Auburn, US HQ
Locations
Cambridge, US HQ
Boulogne Billancourt, FR
Berlin, DE
Dublin 2, IE
Milano, IT
Stockholm, SE
see more
Locations
Menlo Park, US HQ
Philadelphia, US
Locations
Pasadena, US HQ
Madison, US
Locations
Cambridge, US HQ
Employees
Employees
148% increase
Employees
49996% increase
Employees
825% increase
Employees
11625% increase
Employees
2118% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
9 b
Valuation ($)
348.2 m
Valuation ($)
2.5 b
Valuation ($)
656.4 m
Twitter followers
Twitter followers
N/A
Twitter followers
1.8 k
Twitter followers
38
Twitter followers
1.8 k
Twitter followers
3.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
23
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
9
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
21
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
33.2
Average likes per tweet (last 30 days)
1.4
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
88.89%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
269638
Alexa Website Rank
772081
Alexa Website Rank
1069616
Alexa Website Rank
563846

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$301m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$16.1m (FY, 2018)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($361.9m) (FY, 2018)
Net income
($72.6m) (FY, 2018)
Net income
($54.5m) (FY, 2018)
Net income
($85.3m) (FY, 2018)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
12 (FY, 2016)
Patents Issued
359 (FY, 2016)
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 12.5m
Total funding raised
N/A
Total funding raised
$ 70.7m
Total funding raised
$ 147.1m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Sarepta Therapeutics
HQ
Cambridge, US
Employees
499

Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.

View company
Adverum Biotechnologies
HQ
Menlo Park, US
Employees
82↑ 5% increase

Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases.

View company
Arrowhead Pharmaceuticals
HQ
Pasadena, US
Employees
116↑ 25% increase

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.

View company
Intellia Therapeutics
HQ
Cambridge, US
Employees
211↑ 8% increase

Intellia is developing therapeutic products to help people with genetic diseases.

View company